c="total vaginal hysterectomy;" 18:0 18:2||c="hysterectomy" 80:5 80:5||c="tvh" 138:11 138:11||t="coref treatment"
c="her" 21:8 21:8||c="her" 21:12 21:12||c="she" 22:0 22:0||c="she" 23:0 23:0||c="she" 24:0 24:0||c="she" 25:8 25:8||c="her" 25:12 25:12||c="her" 25:19 25:19||c="she" 26:0 26:0||c="the patient" 138:0 138:1||c="the patient" 140:0 140:1||c="the patient" 141:4 141:5||c="the patient" 145:0 145:1||c="the patient" 149:5 149:6||c="the patient" 150:0 150:1||c="the patient" 154:7 154:8||c="the patient" 156:2 156:3||c="the patient" 159:0 159:1||c="the patient" 160:0 160:1||c="the patient" 161:0 161:1||c="her" 162:8 162:8||c="the pt" 163:0 163:1||c="the patient" 164:0 164:1||c="the patient" 165:0 165:1||c="the patient" 167:3 167:4||c="she" 168:0 168:0||t="coref person"
c="pelvic organ prolapse" 16:0 16:2||c="pelvic organ prolapse" 21:4 21:6||c="it" 21:15 21:15||c="the prolapse" 25:0 25:1||c="pelvic organ prolapse" 138:27 138:29||c="pelvic organ prolapse" 190:0 190:2||t="coref problem"
c="a post-operative hematoma" 148:6 148:8||c="the bleeding" 153:12 153:13||c="the bleeding vessel" 157:5 157:7||t="coref problem"
c="sacrospinous colpopexy exploratory laparotomy" 18:12 18:15||c="urgent re-exploration" 149:16 149:17||c="re-exploration with incision" 150:10 150:12||c="exploratory laparotomy" 151:0 151:1||c="laparotomy" 153:1 153:1||c="re-exploration" 158:8 158:8||t="coref test"
c="imperic treatment" 164:16 164:17||c="gent/clinda" 164:19 164:19||c="antibiotics" 166:0 166:0||t="coref treatment"
c="ciprofloxacin" 12:0 12:0||c="cipro" 175:0 175:0||t="coref treatment"
c="flagyl" 12:2 12:2||c="flagyl" 175:2 175:2||t="coref treatment"
c="attending" 13:0 13:0||c="ana k warren , m.d." 14:0 14:4||t="coref person"
c="anterior-posterior colporrhaphy" 18:4 18:5||c="anterior and posterior repair with mesh" 138:18 138:23||t="coref treatment"
c="subpubic urethral sling;" 18:9 18:11||c="sparc" 138:16 138:16||t="coref treatment"
c="reexploration of vaginal surgical area pelvic angiography" 19:0 19:6||c="angiography" 157:9 157:9||t="coref test"
c="loss of urine on valsalva;" 56:9 56:13||c="stress urinary incontinence" 190:3 190:5||t="coref problem"
c="radiolabled red cell study" 68:0 68:3||c="tagged cell and angiographic studies" 158:0 158:4||t="coref test"
c="hemoperitonium" 151:3 151:3||c="retroperitoneal bleed hemoperitoneum" 190:6 190:8||t="coref problem"
c="embolization" 157:13 157:13||c="emobolization" 158:18 158:18||t="coref treatment"
c="active bleeding" 158:14 158:15||c="bleeding" 162:6 162:6||t="coref problem"
c="a low grade fever" 164:3 164:6||c="which" 164:11 164:11||t="coref problem"
